Recent Updates
Recently added Catalysts

Alendronate

Phase 1

Healthy | Small molecule | Other |Dr. Reddy's Laboratories Ltd|Last Updated: Jun 14, 2010

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedACTIVE_CONTROLLEDDMC
Total Trials1
Total Enrollment80

FDA Designations

No designations recorded

Clinical trial landscape

Alendronate · 1 trial · 1 indication

Phase 1 1
NCT01133496Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting ConditionsHealthy
COMPLETED80 Analytics
PHASE1COMPLETED
Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions
HealthyUnlock trial analytics

Study Endpoints

Primary Endpoints

Bioequivalence based on Cmax and AUC parameters
5 months
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
Alendronate SodiumEXPERIMENTALAlendronate Sodium Tablets, 70 mg of Dr. Reddy's
FosamaxACTIVE_COMPARATORFosamax Tablets 70 mg of Merck \& Company. Inc., USA.

Interventions

NameTypeDescription
Alendronate Sodium Tablets, 70 mgDRUGAlendronate Sodium Tablets, 70 mg of Dr. Reddy's Laboratories Limited.
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to 45 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: 1. Healthy human subjects aged between 18 and 45 years (including both). 2. Subjects with a BMI between 18.5 - 24.9 Kg/m2 but weight not less than 45 Kgs. 3. Female subjects who are postmenopausal or surgically sterile. 4. Female subjects of child bearing potential practicing an...

Countries:India
Unlock Eligibility Criteria

Frequently asked questions about Alendronate

What is Alendronate used for?

Alendronate is a small molecule drug being studied in healthy volunteers. It is currently in Phase 1 clinical development by Dr. Reddy's Laboratories Ltd. The drug is being investigated for its bioequivalence, meaning how well a generic version compares to a reference product.

Who makes Alendronate?

Alendronate is being developed by Dr. Reddy's Laboratories Ltd, a pharmaceutical company listed on the stock exchange under the ticker RDY. The company is conducting clinical trials to evaluate the drug's bioequivalence in healthy subjects.

What phase is Alendronate in?

Alendronate is in Phase 1 clinical development. It is an investigational drug, not yet approved by regulatory authorities. The current trial is a bioequivalence study, which is an early-stage study typically conducted to support generic drug applications.

What clinical trials is Alendronate in?

Alendronate has one completed clinical trial, NCT01133496, titled 'Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions.' This Phase 1 study enrolled 80 healthy volunteers in India and was active-controlled, meaning it compared the test drug to a reference product.

Is Alendronate the same as alendronate sodium?

Alendronate is the active ingredient in the drug product, which is formulated as alendronate sodium tablets. The clinical trial NCT01133496 specifically studied alendronate sodium tablets at a 70 mg dose, indicating that alendronate and alendronate sodium refer to the same medication.